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Abstract
Background: Mater and Padi6 are maternal effect genes that are first expressed during oocyte growth and are required for
embryonic development beyond the two-cell stage in the mouse. We have recently found that PADI6 localizes to, and is
required for the formation of, abundant fibrillar Triton X-100 (Triton) insoluble structures termed the oocyte cytoplasmic
lattices (CPLs). Given their similar expression profiles and mutant mouse phenotypes, we have been testing the hypothesis
that MATER also plays a role in CPL formation and/or function.
Methodology/Findings: Herein, we show that PADI6 and MATER co-localize throughout the oocyte cytoplasm following
Triton extraction, suggesting that MATER co-localizes with PADI6 at the CPLs. Additionally, the solubility of PADI6 was
dramatically increased in Mater
tm/tm oocytes following Triton extraction, suggesting that MATER is involved in CPL
nucleation. This prediction is supported by transmission electron microscopic analysis of Mater
+/+ and Mater
tm/tm germinal
vesicle stage oocytes which illustrated that volume fraction of CPLs was reduced by 90% in Mater
tm/tm oocytes compared to
Mater
+/+ oocytes.
Conclusions: Taken together, these results suggest that, similar to PADI6, MATER is also required for CPL formation. Given
that PADI6 and MATER are essential for female fertility, these results not only strengthen the hypothesis that the lattices
play a critical role in mediating events during the oocyte-to-embryo transition but also increase our understanding of the
molecular nature of the CPLs.
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Introduction
A unique feature of mammalian oocytes is that transcription ceases
upon oocyte maturation [1] and does not resume until embryonic
transcription becomes activated in the early embryo [2–5]. During
this period of transcriptional quiescence, the oocyte must rely on
maternal factors, structures, and organelles that have accumulated in
the oocyte during growth to mediate this critical period, often called
the oocyte-to-embryo transition (OET). In non-mammalian species,
mutation analysis has identified a large number of factors, called
maternal effect genes (MEGs), which are synthesized and accumulate
in the oocyte and then persist in the early embryo where they are
required for embryonic development [6,7]. Phenotypic analysis of
mouse knockout models has recently lead to the identification of
several mammalian MEGs such as Maternal Antigen That Embryos
Require (MATER) and Peptidylarginine Deiminase 6 (PADI6), two
highly-abundant oocyte-restricted proteins that are essential for
embryonic development beyond the two-cell stage [8,9].
MATER (gene name, NLRP5) was originally identified as an
antigen that is involved in a mouse autoimmune oophoritis [10].
Recently, MATER (mother in Latin) has been identified as a
component of the SCMC (subcortical maternal complex) along
with other maternal factors including FILIA (daughter in Latin),
FLOPED, and TLE6 [11]. Additionally, PADI6 has also been
putatively identified as a component of the SCMC complex. While
FILIA is thought to play a role in chromosome stability during
embryogenesis [12], the role of MATER remains to be elucidated.
PADI6 was originally cloned from the mouse oocyte proteome
due to its abundance in metaphase II-arrested oocytes and its
oocyte-restricted expression pattern [9]. Interestingly, PADI6 is
localized to, and required for, the formation of an abundant,
oocyte- and early embryo-restricted structure, the cytoplasmic
lattices (CPLs or lattices) [9,13]. The lattices are composed of 5–7
parallel fibers with each fiber containing a repeating unit of
,20 nm [14]. The bundled fibers are first observed at early stages
of oocyte growth (30–40 mm) [15] and persist in the early embryo
until the blastocyst stage [16]. CPLs were found to be resistant to
Triton-X-100 (Triton), thus, extraction with this detergent
provides a valuable tool for studying CPL associated proteins
[14,17]. While CPLs have been observed by electron microscopy
since the 1960s, their function remains poorly understood. Based
on electron microscopy and biochemical analysis, a number of
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granules [18] or as a ribosomal storage site [15,19–23], with the
latter hypothesis being supported by recent data from our lab [24].
Interestingly, Padi6 and Mater share many similar properties. For
example, the expression of both maternal genes is regulated by the
basic helix-loop-helix transcription factor, FIGLA (Factor in the
germline alpha) [25] and is restricted to oocytes and early embryos
in mouse. Microarray analysis [26] along with previous studies
[9,27,28] suggest that both transcripts appear in the oocyte at the
primordial/primary follicle stage and then abruptly disappear
around meiotic maturation. MATER and PADI6 protein expres-
sion roughly parallels that of their transcripts in oocytes; however,
protein levels persist at high levels throughout preimplantation
development until the blastocyst stage [9,27]. Additionally, analysis
of Padi6
2/2 and Mater
tm/tm (tm: targeted mutation) female mice
indicates that the phenotypes of embryos conceived from these two
mutants are strikingly similar with a developmental arrest occurring
at the two-cell stage; likely due to abnormal embryonic genome
activation (EGA) as demonstrated by reduced levels of BrUTP and
TRC transcripts in these embryos [8,13,24].
Based on these similarities, we hypothesized that, similar to
PADI6, MATER may also play a role in CPL formation. Here we
show that PADI6 and MATER co-localize throughout the oocyte
cytoplasm following Triton extraction and appear to both be
associated with large complexes of similar molecular weight.
Additionally, the solubility of PADI6 (a CPL marker) is greatly
increased in Mater hypomorph oocytes, suggesting that lattices are
significantly reduced in Mater
tm/tm oocytes. As a more direct
confirmation of the requirement of MATER for CPL formation,
we show by electron microscopy that the volume of CPLs is
reduced 9.65-fold in germinal vesicle (GV) stage Mater
tm/tm oocytes.
Taken together, these results suggest that MATER is required for
CPL formation. Studies are currently underway to test the
hypothesis that MATER’s role in CPL synthesis is due to direct
interactions with other CPL-associated factors and to further
investigate CPL function using the Mater
tm/tm mouse oocyte model.
Results
PADI6 and MATER co-localize in oocytes and early
embryos and appear to associate with high molecular
weight complexes
The localization of MATER and PADI6 has been reported
previously [9,27,28]. Given that PADI6 primarily localizes to the
CPLs [9] and is required for CPL formation [13], we believe that
PADI6 represents a good marker for the CPLs. Therefore, to
begin testing the hypothesis that MATER plays a role in CPL
function, we first carried out confocal immunofluorescence
microscopy (CIM) to determine if these two maternal factors co-
localize. Oocytes and embryos were fixed with paraformaldehyde
(PFA), permeabilized and stained with anti-PADI6 and anti-
MATER antibodies. The results showed that MATER and
PADI6 appear to strongly co-localize in the cortex and, to a
lesser degree, in the cytoplasm of GV stage oocytes. Co-
localization was also observed at the non-opposed cortex regions
of 2-cell and 4-cell stage embryos with less co-localization being
observed throughout the cytoplasm in the early embryos (Fig. 1A).
Interestingly, in two and four cell embryos, PADI6 staining is
more strongly localized to the cortex than MATER, which can be
seen to penetrate deeper into the cytoplasm. CPLs are Triton
insoluble structures. Therefore, to more directly test the hypothesis
that MATER localizes to the CPLs, we next extracted GV oocytes
with 0.1% Triton for 10 min and then carried out co-localization
analysis using CIM. Following Triton extraction, the cytoplasmic
signal of MATER and PADI6 was greatly enhanced throughout
the oocyte cytoplasm, thus providing an indirect line of evidence
that MATER is associated with the CPLs (Fig. 1B). To test if
MATER and PADI6 co-localize in the extracted oocytes, co-
localization analysis was performed with Zeiss 2007 software and
the scatterplot shows the degree of co-localization between
MATER and PADI6 in the extracted oocytes. Mander’s overlap
and Pearson’s correlation coefficients (0.97 and 0.7, respectively)
confirm the high degree of colocalization between MATER and
PADI6 (Fig. 1B).
To further strengthen the potential association between
MATER and PADI6, we next resolved proteins from GV stage
outbred CD1 mouse oocyte extracts using fast protein liquid
chromatography (FPLC) and eluted fractions were analyzed by
immunoblot using MATER and PADI6 antibodies. Results show
that PADI6 and MATER appear to co-elute in three different
fractions. An initial high molecular weight fraction is seen between
2000 kD and 669 kD, a second fraction is observed between 669
and 220 kD, and a third peak is also seen that is below the 200 kD
molecular weight marker. Additionally, a fraction of PADI6 also
appears to elute independent from MATER just below the 200 kD
marker. The observation that PADI6 and MATER appear to co-
elute in high (,1,000 to 2,000) molecular weight fractions
supports the hypothesis that these two maternal proteins are
associated with a supramolecular complex (Fig. 1C).
The Triton X-100 solubility of PADI6 is increased in
Mater
tm/tm oocytes
The oocyte CPLs cannot be visualized by EM in Padi6 null
mouse oocytes [24], suggesting that the CPLs do not form in the
absence of PADI6 and that proteins which normally associate with
the CPLs are rendered more soluble in the mutant eggs. This idea
is supported by our previous finding that the Triton solubility of
ribosomal components, such as S6, is greatly enhanced in Padi6-
null eggs [24]. Therefore, we decided to use a similar type of
approach in Mater mutant oocytes to more directly test the
hypothesis that MATER plays a role in CPL formation and
function. We predicted that if CPLs do not form in Mater
tm/tm
oocytes, then PADI6 (a CPL-associated protein) should become
more soluble following Triton extraction. GV oocytes were either
not extracted or extracted with 0.1% Triton for 10 minutes and
prepared for CIM as described above. Results showed that, in
non-extracted oocytes, the level and localization of PADI6 was
similar between Mater
+/+ and Mater
tm/tm oocytes with slightly
reduced PADI6 level at the cortex in Mater
tm/tm oocytes. However,
PADI6 levels were dramatically reduced in Mater
tm/tm oocytes
following Triton extraction (Fig. 2A). In order to better quantitate
these findings, we carried out western blot analysis of non-
extracted and Triton extracted oocytes. In line with our confocal
findings, immunoblot analysis showed that PADI6 levels were
similar between wild type and Mater hypomorph oocytes.
However, following Triton extraction, analysis of the insoluble
fraction found that, while levels of b-actin were similar, image
densitometry quantification revealed that levels of PADI6 were
reduced by ,50% in the mutant compared to the control wild
type oocytes (Fig. 2B). Taken together, these results suggest that
the lattices do not form (or form to a lesser degree) in the absence
of MATER, thus releasing PADI6 from the insoluble fraction.
Morphometric electron microscopic analysis reveals that
CPL volume is greatly reduced in Mater
tm/tm oocytes
In order to directly test the hypothesis that MATER is required
for CPL formation, we next performed morphometric analysis of
MATER and Cytoplasmic Lattices
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+/+ and Mater
tm/tm oocytes using transmission
electron microscopy (TEM). GV oocytes were collected from three
Mater
+/+ and three Mater
tm/tm female mice, fixed, embedded with
resin, and ultrathin sections of the blocks were placed on a grid.
The oocytes were then imaged using TEM and quantitation of the
CPLs and other organelles was then carried out using the point-
counting method [29]. Results showed that the average volume
fraction of CPLs per area was 5.5% for Mater
+/+ oocytes and
0.057% for Mater
tm/tm oocytes, thus the volume fraction of CPLs in
Mater
tm/tm oocytes was reduced by 9.56 fold when compared to
Mater
+/+ oocytes. Standard error of mean (SEM) of the CPL
volume fraction for Mater
+/+ oocytes was 0.0035 and for Mater
tm/tm
oocytes was 0.0009 (Fig. 3 and Fig. 4C). This result provides direct
support of our hypothesis that MATER is required for CPL
formation. It is important to note that a residual amount of
MATER protein is present in Mater
tm/tm oocytes (See Fig. 2B and
Discussion below), thus possibly explaining why some lattices are
observed in hypomorph oocytes.
Interestingly, while scoring CPL volume by TEM, we also
noticed that there was an apparent increase in the volume of lipid
droplets in Mater
tm/tm oocytes when compared to Mater
+/+ oocytes
(Fig. 4A). To quantify this observation, we then carried out
morphometric analysis of the LDs in the wild type and mutant
oocytes. Additionally, we also scored mitochondrial and ER
volume to investigate if the volume of these organelles might be
altered in the Mater
tm/tm oocytes. We found that, while the volume
fractions of mitochondria and ER were similar, the volume of lipid
droplets increased approximately 7-fold in Mater
tm/tm oocytes
(Fig. 4C). The finding that mitochondrial volume fraction did not
appear to be affected in Mater
tm/tm oocytes is interesting in light of
previous immuno-EM data showing that MATER localizes, in
part, to mitochondria. Experiments are being carried out to
address this observation. In support of our EM findings on the
increase in lipid droplet volume fraction in Mater
tm/tm oocytes, we
also noticed that the morphology of these oocytes seems distinct
from Mater
+/+ oocytes in that brown aggregates were observed in
Figure 1. Co-localization of MATER and PADI6 in non-extracted and Triton X-100 extracted GV oocytes and early embryos. (A)
Confocal microscopic images show non-extracted GV-stage oocytes, 2-cell, and 4-cell embryos after fixation, permeabilization and incubation with
anti-MATER (green) and anti-PADI6 (red) antibodies. (B) GV oocytes extracted with 0.1% Triton X-100 and stained with MATER (green) and PADI6 (red)
antibodies. Merged images highlight MATER and PADI6 co-localization. Scatter plot indicates a degree of co-localization of MATER and PADI6. Region
A shows pixels with high MATER (green) intensities, region B shows pixels with high PADI6 (red) intensities, and region C shows pixels with both high
MATER (green) and PADI6 (red) intensities. Mander’s overlap coefficient: 0.97, Pearson’s correlation coefficient: 0.7. (C) CD1 mouse oocyte lysates
were chromatographed by FPLC. Eluted fractions (1 ml) were analysed by immunoblotting with antibodies to PADI6 and MATER. Densitometry was
used to generate a graph and the values in fraction 11 were set at a relative intensity of 100%. Elution of each protein standard is indicated by arrow.
doi:10.1371/journal.pone.0012587.g001
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tm/tm oocytes under the dissecting microscope. To test if these
aggregates were LDs, we stained live Mater
+/+ and Mater
tm/tm
oocytes with Nile red and the merged images show that the
aggregates are, in fact, LDs. (Fig. 4B). Finally, while not
quantitated, we also noticed that the LDs also tended to form
larger clusters in Mater
tm/tm oocytes. Quantitation of the CPLs and
organelles is shown in Figure 4C.
Discussion
In this manuscript, we define a new role for MATER by
showing that this maternal effect gene product appears to be
required for CPL formation. Our EM morphometric analysis of
the volume of CPLs in wild type and Mater
tm/tm oocytes provides
the most direct support of this conclusion with results showing that
the volume fraction of CPLs is reduced by ,10-fold in Mater
tm/tm
oocytes when compared to wild type oocytes. It is important to
note here that the Mater
tm/tm mice used in this study were derived
from the same mice that were originally characterized as Mater null
by Tong et al [8]. Subsequently, however, Ohsugi et al [28] later
documented that these mice actually express low levels of MATER
protein, and thus termed the mice Mater
tm/tm or hypomorphs. We
confirmed that these mice do express low levels of MATER
protein and thus used the Mater
tm/tm hypomorph terminology for
this report. Interestingly, in our study, the observed reduction in
CPL volume roughly correlates with the 90% reduction in
MATER protein in the Mater
tm/tm oocytes, suggesting that there
may be a direct 1:1 stoichiometry between MATER and CPLs. In
other words, decreasing MATER protein concentrations would
result in a corresponding decrease in lattice number. Thus, by
extrapolation, we predict that lattices would be absent from true
Mater null oocytes.
With respect to the role of MATER in lattice formation, while it
is possible that MATER functions indirectly (as an upstream
signaling factor for CPL formation, for example), we predict that
MATER’s role in lattice formation is direct via associations with
other CPL components. This prediction is based on our
observation that PADI6 (a bona fide CPL component) and MATER
co-localize with each other throughout the cytoplasm and on
Tashiro’s immuno-EM finding that MATER localizes to the CPLs
[30]. Therefore, MATER appears to represent a component of the
CPL superstructure. Further, the observation that PADI6
solubility is increased in Mater
tm/tm oocytes suggests that MATER
plays a direct role in helping to nucleate CPL-associated proteins
into the mature CPL superstructure and that, in the absence of
MATER, CPL-associated proteins are rendered more soluble.
As noted in the introduction, MATER has also recently been
found to be associated with, and required for, the formation of
another supramolecular complex, termed the SCMC, which also
contains FILIA, TLE6, and FLOPED. Further investigation into
the molecular nature of this complex finds that Mater, Filia, and
Floped-null mice are essential for development beyond the early
cleavage stages of development. At the molecular level, FPLC and
immunoprecipitation analysis suggests that the SCMC is formed
by a direct interaction between FLOPED, MATER and TLE6,
while FILIA appears to associate with the SCMC via direct
interaction with MATER alone. At the subcellular level, these
proteins appear to co-localize at the oocyte subcortex and this
localization becomes asymmetrically restricted to apical cytocortex
of two-cell embryos. In morulae, however, expression of the
SCMC proteins is limited to the non-opposed cytocortex of outer
blastomeres and these proteins are not observed within the inner
cells. This restricted localization pattern has lead to the hypothesis
that the SCMC structure may provide a molecular marker of
embryonic cell lineages and possibly cell fate determinations [11].
While the role of the SCMC in early development remains to be
elucidated, analysis of Filia-null mice suggests that this maternal
factor plays an important role in integrating the spatiotemporal
localization of regulators of euploidy and cell cycle progression
during early development [12].
Interestingly, a very recent report by another group [30] has
further characterized Floped-null mouse oocytes by electron
microscopy and found that CPLs are also absent from these
mutant oocytes, thus indicating that this SCMC protein is also
required for lattice formation. Additionally, they found that, while
confocal immunofluorescence (IF) analysis of isolated oocytes/
embryos suggested that FLOPED localized to the cytocortex as
shown previously [11], immuno-EM analysis indicated that
FLOPED primarily localized at the CPLs throughout the
cytoplasm. The investigators then predicted that this conflict in
FLOPED subcellular localization patterns was due to the inability
of anti-FLOPED antibodies to penetrate the cortex of isolated
oocytes/embryos, thus resulting in a strong cortical FLOPED
staining pattern. They then tested this prediction by staining
paraffin embedded cross-sections of oocytes and embryos and
found that, under these conditions, FLOPED staining was seen
Figure 2. PADI6 Triton X-100 solubility is increased in Mater
tm/tm
GV-stage oocytes. (A) Confocal analysis shows Mater
+/+ and
Mater
tm/tm GV-stage oocytes prior to, and following, extraction with
0.1% Triton X-100. Oocytes were incubated with PADI6 antibodies (red).
(B) Western blotting shows expression of MATER and PADI6 protein in
Mater
+/+ and Mater
tm/tm GV-stage oocytes prior to, and following, 0.1%
Triton X-100 extraction. Isolated oocytes were either extracted or not
extracted with Triton, and then evaluated by Western blotting using
either anti-MATER, anti-PADI6, or anti-b actin antibodies.
doi:10.1371/journal.pone.0012587.g002
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Taken together, the findings by Tashiro et al. indicate that
FLOPED primarily localizes to the CPLs and is also required for
lattice formation.
In this report, we first document the co-localization of MATER
and PADI6 at the cortex of non-extracted oocytes/embryos, and
throughout the cytoplasm of Triton extracted oocytes. We predict
that the punctate co-localization of PADI6 and MATER
throughout the cytoplasm of Triton extracted oocytes is reflective
of the localization of these maternal factors to the Triton-resistant
CPLs. This prediction is supported by our previous immuno-EM
finding showing that PADI6 primarily localizes to the CPLs and
by the new Tashiro publication [30] which shows that, anti-
MATER coated gold particles also localize to the CPLs. While we
currently do not fully understand why PADI6 and MATER
confocal IF staining is primarily limited to the cortex in non-
extracted oocytes, the new findings on FLOPED localization by
Tashiro raise the possibility that the observed cortical localization
of PADI6 and MATER is artifactual in nature. In fact, we have
found that the ratio of cortical versus cytoplasmic PADI6 and
Figure 3. EM analysis reveals that the volume fraction of CPLs is reduced in Mater
tm/tm oocytes. (A) Representative TEM image (x11,500)
of the ultrastructure of Mater
+/+ GV oocytes. A high magnification (x26,500) image of the lattice structure is shown in the inset. (B) Representative
TEM image (x11,500) showing the ultrastructure of Mater
tm/tm GV oocytes. Arrows in A and B indicate CPLs.
doi:10.1371/journal.pone.0012587.g003
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fixation and immunostaining conditions used [27,28]. Alterna-
tively, it is also possible that MATER and PADI6 are associated
with the SCMC at the cortex and with the CPLs throughout the
cytoplasm. The hypothesis that PADI6 is associated with the
SCMC is supported by previous work showing that PADI6
potentially associates with FLOPED, a component of the SCMC
[11]. If this hypothesis is correct, then it is possible that the SCMC
and CPL complexes are structurally related and may exist as a
continuum that cannot be resolved by electron microscopy. Thus,
PADI6, MATER, and likely other proteins could be found to
shuttle between the CPLs and the SCMC. Interestingly, our FPLC
data may provide some support for this prediction. Our analysis
shows that PADI6 and MATER appear to co-elute in three
separate fractions. The initial high molecular weight fraction
(,670 to 2,000) is similar in mass to that shown for MATER and
other SCMC components in the previous report [11]. This finding
supports the hypothesis that PADI6 is a component of the SCMC.
In our study, the observed midrange ,200 to 670 kDa co-elution
peak raises the possibility that MATER and PADI6 may also be
associated with a smaller complex that either may not be directly
associated with a specific structure. We note that the lowest
molecular weight MATER and PADI6 co-elution peaks are well
below the 200 kDa mass marker and predict these fractions
represent monomeric forms of PADI6 and MATER. While it is
currently unclear why Li et al did not also observe the midrange
and lower MW peaks for MATER in their study, a comparison of
protocols finds that we utilized different sized columns which may
have affected protein resolution. Additionally, we also added 0.1%
Trition to our oocyte lysis buffer, which may have affected protein
solubility. It currently remains unclear whether the association
between PADI6 and MATER is direct or indirect. For this study,
we attempted numerous co-immunoprecipitation experiments and
were not able to show an interaction between PADI6 and
MATER. Interestingly, given that PADI6 was identified as a
potential interacting partner with FLOPED and that FLOPED
directly interacts with MATER, it is possible that PADI6 and
MATER indirectly associate via interactions with FLOPED.
An unexpected finding from this study was that, in addition to
the reduction of CPLs in Mater
tm/tm oocytes, the volume of lipid
droplets was significantly increased in the mutant oocytes. LDs are
dynamic organelles that are primarily thought to store energy in
the form of neutral lipids such as triacylglycerols and sterol esters
[31]. In spite of the significant progress in LD research in recent
years, the fundamental mechanisms by which LDs function
remain mostly unknown. This is particularly true for mammalian
oocytes, as there are only a few reports suggesting a role for LDs in
oocyte function [32–35]. Interestingly, LD accumulation is
Figure 4. Mater
tm/tm oocytes display elevated levels of lipid droplets. (A) Low magnification (x1,700) TEM images of Mater
+/+ and Mater
tm/tm
GV-stage oocytes. Oocytes were prepared for TEM as above. White arrows point to LDs. (B) Confocal images of GV-stage live Mater
+/+ and Mater
tm/tm
oocytes following Nile red staining. DIC images show morphology of LDs in oocytes. Close up images (Right panel) highlight LD aggregates. Arrows
indicate LDs. (C) Quantitation of the volume fractions of CPLs, LDs, mitochondria, and ER in Mater
+/+ and Mater
tm/tm GV-stage oocytes. Mean 6 SEM is
indicated. P value is ,0.004 for CPLs, ,0.04 for LD, .0.05 for mitochondria, and ER.
doi:10.1371/journal.pone.0012587.g004
MATER and Cytoplasmic Lattices
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12587frequently seen in pathologic conditions such as apoptosis, cancer,
and inflammation [36]. A recent report has found an interaction
between MATER and PKC {epsilon}, which is involved in the
anti-apoptotic pathway [36,37]. If MATER is indeed associated
with an anti-apoptotic signaling pathway, LD accumulation in
Mater
tm/tm oocytes may be associated with apoptotic events.
Importantly, our findings indicate that Mater
tm/tm mice represent
a valuable tool to study LD function in oocytes.
To conclude, in this study we show that MATER is required for
CPL formation and also appears to represent a component of the
CPL superstructure. In light of the new finding by Tashiro that
another SCMC component, i.e. FLOPED, is also required for
CPL formation, and that PADI6 was identified at a putative
FLOPED interacting proteins, our new findings now highlight a
potential relationship between the SCMC and the CPLs.
Additionally, given the oocyte/embryo-restricted nature of PADI6
and MATER and that these factors are all essential for early
cleavage divisions, these findings further highlight the importance
of the CPLs in mediating the oocyte-to-embryo transition.
Furthermore, given that MATER and PADI6 are both expressed
in human oocytes, a better understanding of the role of murine
MATER, PADI6, and the lattices in early developmental events
may provide insight into human infertility.
Materials and Methods
Ethics statement
Animals were bred and maintained in accordance with Cornell
animal care guidelines and animal protocol number 2007-0113
was approved by the Cornell Institutional Animal Care and Use
Committee before implementation.
Animals
The generation and validation of the Mater
tm/tm mouse strain has
been described previously [8]. CD-1 breeding mice were
purchased from commercial vendors.
Collection and culture of oocytes and embryos
Oocytes were harvested from 4- to 6-week-old Mater
+/+ and
Mater
tm/tm mice. GV-stage oocytes were harvested 46–48 hours after
intraperitoneal injection of 5IU pregnant mare serum gonadotrophin
(PMSG). 46–48 hours post PMSG, 5IU of human chorionic
gonadotrophin (hCG) was administered intraperitonealy and Meta-
phase II (MII) oocytes were harvested 12–14 hours later. Oocytes
were collected in M2 medium (Sigma) and 5 mM milrinone (Sigma)
or 200 mM IBMX (Sigma) was added to the media when GV oocytes
were used. For collection of preimplantation embryos, mice were
superovulated with PMSG/hCG as above, mated, and two-cell and
four-cell embryos were collected 2 and 3 days later, respectively.
Confocal microscopy
Immunostaining and Triton extraction procedures for oocytes
have been described elsewhere (Yurttas et al., 2008). Oocytes and
embryos were fixed in 4% paraformaldedyde (PFA) (EM Sciences)
for 30 minutes. For extraction, oocytes were incubated in
extraction buffer containing 0.1M KCl, 20 mM MgCl2,3m M
EGTA, 20 mM HEPES (pH 6.8), 0.1% Triton X-100 and 16
Complete Protease Inhibitor Cocktail (Roche) for 10 minutes and
rinsed in PBS quickly and fixed. Oocytes were permeabilized with
0.5% Triton X-100 in PBS for 30 minutes, washed and incubated
with rabbit anti-MATER (1:1000) (Tong et al., 2004) or guinea pig
anti-PADI6 (1:1000) (Wright et al., 2003) in IF buffer (1% BSA,
0.5% Normal Goat Serum in PBS) for 1 hour followed by another
1 h incubation with the appropriate Alexa Fluor-conjugated
(1:450) secondary antibody (Molecular Probes) in IF buffer.
Oocytes were mounted on slides with Slowfade Gold antifade
agent (Molecular Probes) and imaged using an LSM 510 laser
scanning confocal microscope (Carl Zeiss). Confocal microscope
settings for comparison of MATER expression between Mater
+/+
and Mater
tm/tm oocytes were identical. For Nile red staining,
oocytes were quickly washed 5 times in M2 medium, 3 times in
MEM alpha medium (Invitrogen), and then incubated with Nile
red (Sigma, 5 mg/1 ml) in MEM alpha medium for 5 minutes.
Oocytes were briefly washed in PBS/PVA and PBS, attached to
MatTek dishes (MatTek Corporation), which were then filled
with MEM alpha. All procedures were carried out at room
temperature.
Gel Filtration Chromatography
Eighty GV oocytes were collected from ovaries of CD-1 female
mice. Using an AKTApurifier FPLC System (GE Healthcare),
oocyte lysates were chromatographed on a superpose 6 K9/30
column pre-equilibrated with several column volumes of chroma-
tography buffer containing 154 mM NaCl, 50 mM Na phosphate
(PH 7.4), 5 mM EDTA, and 0.02% NaN3. Elution positions of
molecular weight standards (Sigma) were used to calibrate the
column and determine the void volume. Fractions (1.0 ml) were
transferred to a PVDF membrane by slot blot manifold (Hoefer
PR 648) and analyzed by immunoblot. FPLC experiments were
repeated two times. The immunoblot was scanned and relative
intensity of bands was measured by ImageJ.
Western blotting
Mater
+/+ and Mater
tm/tm GV oocytes (15 for non-extracted and
25 for extracted), were collected, lysed in 4X Laemmli buffer
(8% SDS, 40% glycerol, 20% 2-mercaptoethanol, 0.25M Tris
HCl pH 6.8, 0.008% bromophenol blue), and boiled for 10
minutes at 100uC. Samples were run on a 10% SDS-PAGE gel
at 100–120 V and transferred to PVDF membranes at 250mA
for 2 hours. Membranes were blocked with 5% milk in 0.1%
TBS-T overnight at 4uC and subsequently incubated with
PADI6 (1:13,000), MATER (1:12,000), and b-actin (1:1,000,
Abcam) antibodies for 1–2 hour followed by anti-guinea pig
(1:15,000), anti-rabbit (1:15,000) HRP antibody (Jackson Im-
munoResearch) for 1 hour. Blots were developed using Im-
mobilon Western HRP Chemiluminescent Substrate (Millipore).
Films were scanned and densitometry was performed by Adobe
photoshop CS4 program.
Transmission electron microscopy
Electron microscopy was performed as described elsewhere [24]
with the following modifications. GV oocytes were collected from
age-matched 4–6 week old Mater
+/+ and Mater
tm/tm mice (three
mice each) and immediately fixed with 2.5% Glutaraldehyde (EM
Sciences), 4% PFA, 0.1% tannic acid and 0.01M MgCl2 in 0.1M
sodium cacodylate buffer (pH 7.3) at room temperature for
2 hours then overnight at 4uC. The oocytes were post-fixed with
1% osmium teroxide in cacodylate buffer for 1 hour, en bloc
stained with 2% uranyl acetate, dehydrated in a graded ethanol
series and then embedded in LX-112 resin (Ladd Research). Thin
sections (50–70 nm) were cut with a diamond knife (Diatome) on
an AO/Reichert ultramicrotome and picked up on nickel 200
mesh thin bar grids. Grids are contrast stained with 2% uranyl
acetate followed by Sato’s modified lead stain. Samples were
examined by a FEI T12 TWIN transmission electron microscopy
(TEM) at 100kV and images were collected with a Gatan OriusH
dual-scan CCD camera.
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For morphometric analysis, TEM images (x 11,500) were
overlayed with a 2106 cross point grid (0.8 cm spacing) using
ImageJ, and points occupied by CPLs, LDs, mitochondria, and ER
were scored using the point-counting method [29]. The scoring was
performed on 18 randomly spaced thin sections, with 3 sections from
each of 6 different oocytes, which were obtained from 3 independent
biological replicates of both Mater
+/+ and Mater
tm/tm mice.
Statistical analysis
Means and standard error of the mean (SEM) were calculated
for organelle volume fraction of Mater
+/+ and Mater
tm/tm oocytes
and statistical significance was calculated using a two-tailed t-test
in Microsoft Excel 2007 program. P-value,0.05 was regarded as
statistically significant. All experiments were repeated at least three
times unless written otherwise.
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